Non-invasive diagnosis of non-alcoholic fatty liver disease: Current status and future perspective
Non-alcoholic fatty liver disease (NAFLD) is the most common cause of chronic liver disease throughout the world. Hepatocellular carcinoma (HCC) and liver cirrhosis can result from nonalcoholic steatohepatitis (NASH), the severe stage of NAFLD progression. By some estimates, NAFLD affects almost one...
| Published in: | Heliyon |
|---|---|
| Main Authors: | Jia-Lan Wang, Su-Wen Jiang, Ai-Rong Hu, Ai-Wu Zhou, Ting Hu, Hong-Shan Li, Ying Fan, Ken Lin |
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2024-03-01
|
| Subjects: | |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S2405844024033565 |
Similar Items
Improvement of Diagnostic Algorithm in Patients With Alcoholic Fatty Liver Disease by Using Non-invasive Methods of Verification of Liver Steatosis and Fibrosis
by: Svintsitskyy A., et al.
Published: (2016-07-01)
by: Svintsitskyy A., et al.
Published: (2016-07-01)
Progressive Liver Fibrosis in Non-Alcoholic Fatty Liver Disease
by: Daryl Ramai, et al.
Published: (2021-12-01)
by: Daryl Ramai, et al.
Published: (2021-12-01)
Non-alcoholic fatty liver disease: Definition and subtypes
by: Seul Ki Han, et al.
Published: (2023-02-01)
by: Seul Ki Han, et al.
Published: (2023-02-01)
Use of a controlled attenuation parameter for the diagnosis of non-alcoholic fatty liver disease
by: Alexey A. Goncharov, et al.
Published: (2023-10-01)
by: Alexey A. Goncharov, et al.
Published: (2023-10-01)
Triglyceride Glucose Index is Associated with Ultrasonographic Fatty Liver Indicator in Children and Adolescents with Non-alcoholic Fatty Liver Disease
by: Bitgyeol Kim, et al.
Published: (2024-09-01)
by: Bitgyeol Kim, et al.
Published: (2024-09-01)
Trends and insights in non-alcoholic fatty liver disease (NAFLD) and cognition research
by: Anam Rehman Rehman, et al.
Published: (2025-03-01)
by: Anam Rehman Rehman, et al.
Published: (2025-03-01)
RISK FACTORS FOR HEPATOCELLULAR CARCINOMA IN PATIENTS WITH NON-ALCOHOLIC FATTY LIVER DISEASE
by: Lourianne Nascimento CAVALCANTE, et al.
Published: (2022-11-01)
by: Lourianne Nascimento CAVALCANTE, et al.
Published: (2022-11-01)
Non-Invasive Serum Markers of Non-Alcoholic Fatty Liver Disease Fibrosis: Potential Tools for Detecting Patients with Cardiovascular Disease
by: Ling-Zi Chen, et al.
Published: (2024-09-01)
by: Ling-Zi Chen, et al.
Published: (2024-09-01)
Should you advocate for hepatocellular carcinoma surveillance in patients with alcohol-related liver disease or non-alcoholic fatty liver disease?
by: Ju Hyun Shim
Published: (2020-04-01)
by: Ju Hyun Shim
Published: (2020-04-01)
Correspondence on Letter regarding “Non-alcoholic fatty liver disease: Definition and subtypes”
by: Seul Ki Han, et al.
Published: (2023-07-01)
by: Seul Ki Han, et al.
Published: (2023-07-01)
Platelets in Non-alcoholic Fatty Liver Disease
by: Andrea Dalbeni, et al.
Published: (2022-02-01)
by: Andrea Dalbeni, et al.
Published: (2022-02-01)
Relationship between serum 25-hydroxyvitamine D and non-alcoholic fatty liver disease
by: S.M. Tkach, et al.
Published: (2023-05-01)
by: S.M. Tkach, et al.
Published: (2023-05-01)
Body Composition and Progression of Biopsy‐Proven Non‐Alcoholic Fatty Liver Disease in Patients With Obesity
by: Qianyi Wan, et al.
Published: (2024-12-01)
by: Qianyi Wan, et al.
Published: (2024-12-01)
Liver Cirrhosis as the Outcome of Non-Alcoholic Fatty Liver Disease Associated with PNPLA3 Gene RS738409 Polymorphism
by: I. G. Nikitin, et al.
Published: (2020-03-01)
by: I. G. Nikitin, et al.
Published: (2020-03-01)
Mean Platelet Volume in Patients with Non-Alcoholic Fatty Liver Disease
by: Miryala Srikar, et al.
Published: (2021-07-01)
by: Miryala Srikar, et al.
Published: (2021-07-01)
Heterogeneous population of macrophages in the development of non-alcoholic fatty liver disease
by: Ye Eun Cho, et al.
Published: (2023-03-01)
by: Ye Eun Cho, et al.
Published: (2023-03-01)
Unlocking the Therapeutic Potential of Ellagic Acid for Non-Alcoholic Fatty Liver Disease and Non-Alcoholic Steatohepatitis
by: Tharani Senavirathna, et al.
Published: (2024-04-01)
by: Tharani Senavirathna, et al.
Published: (2024-04-01)
Non-alcoholic fatty liver disease and cardiovascular pathology: pathogenetic parallels
by: G. Yu. Knorring, et al.
Published: (2024-08-01)
by: G. Yu. Knorring, et al.
Published: (2024-08-01)
Pediatric non-alcoholic fatty liver disease
by: Delvin Edgard, et al.
Published: (2015-01-01)
by: Delvin Edgard, et al.
Published: (2015-01-01)
A scoring system for the diagnosis of non-alcoholic steatohepatitis from liver biopsy
by: Kyoungbun Lee, et al.
Published: (2020-05-01)
by: Kyoungbun Lee, et al.
Published: (2020-05-01)
Non-alcoholic fatty liver disease development: A multifactorial pathogenic phenomena
by: Aamir Bashir, et al.
Published: (2022-06-01)
by: Aamir Bashir, et al.
Published: (2022-06-01)
Liver Injury and Cell Survival in Non-Alcoholic Steatohepatitis Regulated by Sex-Based Difference through B Cell Lymphoma 6
by: Akihide Kamiya, et al.
Published: (2022-11-01)
by: Akihide Kamiya, et al.
Published: (2022-11-01)
Transcriptional Regulation in Non-Alcoholic Fatty Liver Disease
by: Sandra Steensels, et al.
Published: (2020-07-01)
by: Sandra Steensels, et al.
Published: (2020-07-01)
Non-Alcoholic Fatty Liver Disease, Atherosclerosis, and Cardiovascular Disease in Asia
by: Yohwan Lim, et al.
Published: (2023-06-01)
by: Yohwan Lim, et al.
Published: (2023-06-01)
Non-alcoholic fatty liver disease in women – Current knowledge and emerging conceptsKey points
by: Pei Chia Eng, et al.
Published: (2023-10-01)
by: Pei Chia Eng, et al.
Published: (2023-10-01)
Pharmacotherapy for Non-Alcoholic Fatty Liver Disease: Emerging Targets and Drug Candidates
by: Veronika A. Prikhodko, et al.
Published: (2022-01-01)
by: Veronika A. Prikhodko, et al.
Published: (2022-01-01)
Non-invasive biomarkers of liver fibrosis in non-alcoholic fatty liver disease
by: Maamon Basheer, et al.
Published: (2023-04-01)
by: Maamon Basheer, et al.
Published: (2023-04-01)
Diagnostic accuracy of apoptosis markers in non-alcoholic fatty liver disease in children
by: Yu. M. Stepanov, et al.
Published: (2020-12-01)
by: Yu. M. Stepanov, et al.
Published: (2020-12-01)
Periostin Circulating Levels and Genetic Variants in Patients with Non-Alcoholic Fatty Liver Disease
by: Carlo Smirne, et al.
Published: (2020-11-01)
by: Carlo Smirne, et al.
Published: (2020-11-01)
SGLT-2 Inhibitors for Non-Alcoholic Fatty Liver Disease: A Review
by: Rong Xu, et al.
Published: (2023-07-01)
by: Rong Xu, et al.
Published: (2023-07-01)
Epidemiologic features of non-alcoholic fatty liver disease in Russia
by: O. M. Drapkina, et al.
Published: (2014-10-01)
by: O. M. Drapkina, et al.
Published: (2014-10-01)
Genetic aspects of non-alcoholic fatty liver disease development
by: V. A. Akhmedov, et al.
Published: (2021-06-01)
by: V. A. Akhmedov, et al.
Published: (2021-06-01)
Association of Inflammatory Cytokines With Non-Alcoholic Fatty Liver Disease
by: Yamei Duan, et al.
Published: (2022-05-01)
by: Yamei Duan, et al.
Published: (2022-05-01)
Pemafibrate Ameliorates Liver Dysfunction and Fatty Liver in Patients with Non-Alcoholic Fatty Liver Disease with Hypertriglyceridemia: A Retrospective Study with the Outcome after a Mid-Term Follow-Up
by: Suguru Ikeda, et al.
Published: (2021-12-01)
by: Suguru Ikeda, et al.
Published: (2021-12-01)
Activation and Functional Priming of Blood Neutrophils in Non-Alcoholic Fatty Liver Disease Increases in Non-Alcoholic Steatohepatitis
by: Lauszus JS, et al.
Published: (2021-11-01)
by: Lauszus JS, et al.
Published: (2021-11-01)
Research progress of drugs targeting ferroptosis for the treatment of non-alcoholic fatty liver disease
by: HAO Dandan, ZHANG Lei, BAI Chunying
Published: (2023-08-01)
by: HAO Dandan, ZHANG Lei, BAI Chunying
Published: (2023-08-01)
ALS-L1023 from <i>Melissa officinalis</i> Alleviates Liver Fibrosis in a Non-Alcoholic Fatty Liver Disease Model
by: Eun Jeoung Lee, et al.
Published: (2022-12-01)
by: Eun Jeoung Lee, et al.
Published: (2022-12-01)
Adaptation of Clinical Practice Guideline for Assessment of Liver Fibrosis in Patients with Non Alcoholic Fatty Liver Disease in Isfahan Province
by: Sayed Mohammad Hosseeini, et al.
Published: (2024-08-01)
by: Sayed Mohammad Hosseeini, et al.
Published: (2024-08-01)
NON-ALCOHOLIC FATTY LIVER DISEASE OUTCOMES FUNNEL
by: D. V. Blinov
Published: (2015-12-01)
by: D. V. Blinov
Published: (2015-12-01)
Transcriptional and Epigenetic Alterations in the Progression of Non-Alcoholic Fatty Liver Disease and Biomarkers Helping to Diagnose Non-Alcoholic Steatohepatitis
by: Yalan Zhu, et al.
Published: (2023-03-01)
by: Yalan Zhu, et al.
Published: (2023-03-01)
Similar Items
-
Improvement of Diagnostic Algorithm in Patients With Alcoholic Fatty Liver Disease by Using Non-invasive Methods of Verification of Liver Steatosis and Fibrosis
by: Svintsitskyy A., et al.
Published: (2016-07-01) -
Progressive Liver Fibrosis in Non-Alcoholic Fatty Liver Disease
by: Daryl Ramai, et al.
Published: (2021-12-01) -
Non-alcoholic fatty liver disease: Definition and subtypes
by: Seul Ki Han, et al.
Published: (2023-02-01) -
Use of a controlled attenuation parameter for the diagnosis of non-alcoholic fatty liver disease
by: Alexey A. Goncharov, et al.
Published: (2023-10-01) -
Triglyceride Glucose Index is Associated with Ultrasonographic Fatty Liver Indicator in Children and Adolescents with Non-alcoholic Fatty Liver Disease
by: Bitgyeol Kim, et al.
Published: (2024-09-01)
